Literature DB >> 17245111

An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis.

Malte Buchholz1, Volker Ellenrieder.   

Abstract

The NFAT proteins are a family of Ca2+/calcineurin-responsive transcription factors primarily recognized for their central roles in T lymphocyte activation. Recent studies, however, have demonstrated that the vital role of NFAT signaling is by no means restricted to the immune system. NFAT proteins are potent mediators of Ca2+ signals in many mammalian cells and tissues and control, among others, important steps in myogenesis, chondrocyte differentiation and the development of the cardiovascular system. Owing to the broad spectrum of target genes and the fundamental nature of the cellular processes they control, it comes as no surprise that NFAT proteins are increasingly being recognized as central players in the development of a number of very different human malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245111     DOI: 10.4161/cc.6.1.3650

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

Review 1.  Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer.

Authors:  Alexander König; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

2.  Calcineurin Regulatory Subunit Calcium-Binding Domains Differentially Contribute to Calcineurin Signaling in Saccharomyces cerevisiae.

Authors:  Sean Connolly; Devona Quasi-Woode; Laura Waldron; Christian Eberly; Kerri Waters; Eric M Muller; Tami J Kingsbury
Journal:  Genetics       Date:  2018-05-07       Impact factor: 4.562

3.  Regulatory subunit myristoylation antagonizes calcineurin phosphatase activation in yeast.

Authors:  Sean Connolly; Tami Kingsbury
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

4.  Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.

Authors:  Yoichi Imai; Eri Ohta; Shu Takeda; Satoko Sunamura; Mariko Ishibashi; Hideto Tamura; Yan-Hua Wang; Atsuko Deguchi; Junji Tanaka; Yoshiro Maru; Toshiko Motoji
Journal:  JCI Insight       Date:  2016-04-21

5.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

Review 6.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

7.  Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis.

Authors:  Elena Adinolfi; Maria Giulia Callegari; Maria Cirillo; Paolo Pinton; Carlotta Giorgi; Dario Cavagna; Rosario Rizzuto; Francesco Di Virgilio
Journal:  J Biol Chem       Date:  2009-02-09       Impact factor: 5.157

8.  Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation.

Authors:  V Tosello; F Bordin; J Yu; V Agnusdei; S Indraccolo; G Basso; A Amadori; E Piovan
Journal:  Leukemia       Date:  2015-12-09       Impact factor: 11.528

9.  NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure.

Authors:  R J Flockhart; B L Diffey; P M Farr; J Lloyd; N J Reynolds
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

10.  NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

Authors:  R J Flockhart; J L Armstrong; N J Reynolds; P E Lovat
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.